Isogarcinol Is a New Immunosuppressant

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Cen, Juren ^a   Shi, Mingshu ^a   Yang, Yanfang ^b   Fu, Yanxia ^a   Zhou, Hailing ^a   Wang, Mengqi ^a   Su, Zhenyi ^a   Wei, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CONCANAVALIN A; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; ISOGARCINOL; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GRAFT SURVIVAL; IMMUNOMODULATION; IN VIVO STUDY; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SKIN TRANSPLANTATION; SURVIVAL TIME; T LYMPHOCYTE;

ALLOGRAFTS; ANIMALS; BIOLOGICAL PRODUCTS; CALCINEURIN; ENZYME ACTIVATION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; PLANT EXTRACTS; RATS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRACHEOBIONTA;

ANIMALIA; GARCINIA MANGOSTANA; MURINAE; MUS;

EID: 84879063245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066503     Document Type: Article

References (44)

1. Roy J, Cyert MS, (2009) Cracking the phosphatase code: docking interactions determine substrate specificity. Science Signalling 2: re9.
2. Shi Y, (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139: 468.
3. Rusnak F, Mertz P, (2000) Calcineurin: form and function. Physiological reviews 80: 1483-1521.
4. Baksh S, Burakoff SJ, (2000) The role of calcineurin in lymphocyte activation. 12 (4): 405-415.
5. Cardenas ME, Sanfridson A, Cutler NS, Heitman J, (1998) Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends in biotechnology 16: 427-433.
6. Schreiber SL, (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
7. Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, et al. (2003) c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. The EMBO journal 22: 5079-5089.
8. Vega RB, Bassel-Duby R, Olson EN, (2003) Control of cardiac growth and function by calcineurin signaling. Journal of Biological Chemistry 278: 36981-36984.
9. Bierer BE, Holländer G, Fruman D, Burakoff SJ, (1993) Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Current opinion in immunology 5: 763-773.
10. Clipstone NA, Crabtree GR, (1993) Calcineurin Is a Key Signaling Enzyme in T Lymphocyte Activation and the Target of the Immunosuppressive Drugs Cyclosporin A and FK506a. Annals of the New York Academy of Sciences 696: 20-30.
11. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, et al. (1996) The mechanism of action of cyclosporin A and FK506. Clinical immunology and immunopathology 80: S40-S45.
12. Jørgensen KA, Koefoed-Nielsen P, Karamperis N, (2003) Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scandinavian journal of immunology 57: 93-98.
13. Hong JC, Kahan BD, (2000) Immunosuppressive agents in organ transplantation: past, present, and future. 20 (2): 108.
14. Pedraza-Chaverri J, Cárdenas-Rodríguez N, Orozco-Ibarra M, Pérez-Rojas JM, (2008) Medicinal properties of mangosteen (Garcinia mangostana). Food and chemical toxicology 46: 3227-3239.
15. Cui J, Hu W, Cai Z, Liu Y, Li S, et al. (2010) New medicinal properties of mangostins: Analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacology Biochemistry and Behavior 95: 166-172.
16. Yu L, Zhao M, Yang B, Zhao Q, Jiang Y, (2007) Phenolics from hull of Garcinia mangostana fruit and their antioxidant activities. Food Chemistry 104: 176-181.
17. Lei H, Luo J, Tong L, Peng L, Qi Y, et al. (2011) Quercetin binds to calcineurin at a similar region to cyclosporin A and tacrolimus. Food Chemistry 127: 1169-1174.
18. Lei H, Qi Y, Jia Z, Lin W, Wei Q, (2009) Studies on the interactions of kaempferol to calcineurin by spectroscopic methods and docking. Biochimica et Biophysica Acta (BBA)-Proteins & Proteomics 1794: 1269-1275.
19. Li J, Tu Y, Tong L, Zhang W, Zheng J, et al. (2010) Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity. Pharmaceutical biology 48: 1177-1184.
20. Peng L, Qi Y, Wu H, Wei Q, (2011) Interaction of glycyrol with calcineurin A studied by spectroscopic methods and docking. IUBMB life 63: 14-20.
21. Wang H, Zhou CL, Lei H, Wei Q, (2010) Inhibition of calcineurin by quercetin in vitro and in Jurkat cells. Journal of biochemistry 147: 185-190.
22. Wang H, Zhou CL, Lei H, Zhang SD, Zheng J, et al. (2008) Kaempferol: a new immunosuppressant of calcineurin. IUBMB life 60: 549-554.
23. Wang H, Du Y, Xiang B, Lin W, Wei Q, (2008) The regulatory domains of CNA have different effects on the inhibition of CN activity by FK506 and CsA. IUBMB life 59: 388-393.
24. Moussay E, Palissot V, Vallar L, Poirel HA, Wenner T, et al. (2010) Research Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
25. Stallard N, Whitehead A, (1995) Reducing animal numbers in the fixed-dose procedure. Human & experimental toxicology 14: 315-323.
26. Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, et al. (2002) Low dose of resveratrol enhanced immune response of mice. Acta Pharmacologica Sinica 23: 893-897.
27. Zhou R, Zhang F, He PL, Zhou WL, Wu QL, et al. (2005) (5 R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo. International immunopharmacology 5: 1895-1903.
28. Shen J (2006) Studies on the chemical constituents in two species plants of Garcinia: Chinese Peking Union Medical College.
29. Cuesta-Rubio O, Piccinelli AL, Rastrelli L, (2005) Chemistry and biological activity of polyisoprenylated benzophenone derivatives. Studies in Natural Products Chemistry 32: 671-720.
30. Marti G, Eparvier V, Litaudon M, Grellier P, Guéritte F, (2010) A new xanthone from the bark extract of rheedia acuminata and antiplasmodial activity of its major compounds. Molecules 15: 7106-7114.
31. Rukachaisirikul V, Naklue W, Sukpondma Y, Phongpaichit S, (2005) An antibacterial biphenyl derivative from Garcinia bancana MIQ. Chemical and pharmaceutical bulletin 53: 342-343.
32. Iinuma M, Tosa H, Tanaka T, Kanamaru S, Asai F, et al. (1996) Antibacterial activity of some Garcinia benzophenone derivatives against methicillin-resistant Staphylococcus aureus. Biological & pharmaceutical bulletin 19: 311.
33. Ito C, Itoigawa M, Miyamoto Y, Onoda S, Rao KS, et al. (2003) Polyprenylated Benzophenones from Garcinia a ssigu and Their Potential Cancer Chemopreventive Activities. Journal of natural products 66: 206-209.
34. Matsumoto K, Akao Y, Kobayashi E, Ito T, Ohguchi K, et al. (2003) Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biological and Pharmaceutical Bulletin 26: 569-571.
35. Mantelingu K, Reddy B, Swaminathan V, Kishore AH, Siddappa NB, et al. (2007) Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chemistry & biology 14: 645-657.
36. Kobayashi K, Kaneda K, Kasama T, (2001) Immunopathogenesis of delayed-type hypersensitivity. Microscopy research and technique 53: 241-245.
37. Issa F, Schiopu A, Wood KJ, (2010) Role of T cells in graft rejection and transplantation tolerance. Expert review of clinical immunology 6: 155-169.
38. Li X, Hu Y, He L, Wang S, Zhou H, et al. (2012) Icaritin inhibits T cell activation and prolongs skin allograft survival in mice. International immunopharmacology.
39. Salem ML, (2005) Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. International immunopharmacology 5: 1749-1770.
40. Gonsette R, (2004) New immunosuppressants with potential implication in multiple sclerosis. Journal of the neurological sciences 223: 87-93.
41. Bennett WM, Norman DJ, (1986) Action and toxicity of cyclosporine. Annual review of medicine 37: 215-224.
42. Thomson A, Whiting P, Simpson J, (1984) Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Inflammation Research 15: 306-327.
43. Lechler RI, Sykes M, Thomson AW, Turka LA, (2005) Organ transplantation-how much of the promise has been realized? Nature medicine 11: 605-613.
44. Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, (2012) Immunosuppressants: A Review. The Pharma Innovation- Journal 1: 90-101.